Clinical trial
Multicentre Clinical Trial to Assess the Performance of Culture-free, End-to-end Targeted NGS (tNGS) Solutions for Diagnosis of Drug Resistant TB (DR-TB)
NCT04239326 is registered in ClinicalTrials.gov with Foundation for Innovative New Diagnostics, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicentre Clinical Trial to Assess the Performance of Culture-free, End-to-end Targeted NGS (tNGS) Solutions for Diagnosis of Drug Resistant TB (DR-TB)
- Lead sponsor
- Foundation for Innovative New Diagnostics, Switzerland
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 16, 2021
- Completion date
- June 30, 2023
- Enrollment
- 800 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.